About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Nephrocare Health Services Ltd.
BSE Code
544647
ISIN Demat
INE428V01029
Book Value
90.17
NSE Code
NEPHROPLUS
Dividend Yield %
0.00
Market Cap
59527.13
P/E
173.87
EPS
3.41
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
27-Feb-2026
12388
7340
59.25
26-Feb-2026
36723
21561
58.71
25-Feb-2026
7983
3689
46.21
24-Feb-2026
3143
1601
50.94
23-Feb-2026
7083
3736
52.75
20-Feb-2026
7686
3746
48.74
19-Feb-2026
4699
2909
61.91
18-Feb-2026
6071
3111
51.24
17-Feb-2026
14727
6536
44.38
16-Feb-2026
10190
6138
60.24
13-Feb-2026
25707
11784
45.84
12-Feb-2026
19289
7807
40.47
11-Feb-2026
556200
175600
31.57
10-Feb-2026
10759
3861
35.89
09-Feb-2026
10264
6077
59.21
06-Feb-2026
9158
2899
31.66
05-Feb-2026
11582
5164
44.59
04-Feb-2026
7835
4433
56.58
03-Feb-2026
14457
8186
56.62
02-Feb-2026
26824
21119
78.73
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.